|
Market Closed -
Euronext Paris
03:55:00 03/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 3.120 EUR | +3.04% |
|
+27.04% | -53.43% |
| 30/10 | Adocia discloses results, cash runway extended through the first quarter of 2028 |  |
| 30/10 | Adocia SA Reports Unaudited Revenue Results for the Nine Months Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 67.64M | |||||
| 63.77B | |||||
| 56.37B | |||||
| 54.62B | |||||
| 44.06B | |||||
| 42.11B |
- Stock Market
- Stocks
- ADOC Stock
- Charts Adocia
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
